Fig. 1From: The 23-valent pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis: a double-blinded, randomized, placebo-controlled trialFlow diagram of patient enrollment. IRB institutional review board, ITT intention-to-treat, PPSV23 23-valent pneumococcal polysaccharide vaccineBack to article page